Vibe Growth Corporation Announces Opening of Its Newest Dispensary in Salinas, California

Vibe’s newest dispensary, located in Salinas, California, opens its doors to the public for adult-use sales

Sacramento, California–(Newsfile Corp. – July 15, 2022) – Vibe Growth Corporation (CSE: VIBE) (OTCQX: VIBEF) (FSE: A061) (the “Company” or “Vibe“), a vertically integrated California cannabis enterprise, is pleased to announce the opening of its newest dispensary location in Salinas, California.

The new Vibe By California branded Salinas dispensary is located at 1031 El Camino Real, Salinas, CA and will be open for adult-use cannabis sales from 9 am to 9 pm. Vibe’s newest dispensary offers exceptional direct access and visibility on U.S. Route 101, providing consumers with a wide selection of leading cannabis brands and products.

“We are thrilled to be opening our doors to the Salinas community finally, and providing our customers with the largest selection of premium cannabis products and a wonderful retail experience,” stated Mark Waldron, CEO of Vibe. “We are so excited to expand Vibe’s customer base and provide the Salinas region with the best-in-class service and unbeatable product selection for which Vibe and Hype are known. We look forward to embracing the local community and providing our customers with the largest selection of premium cannabis products grown right in the Salinas Valley. We think Salinas has the potential to be Vibe’s biggest, most successful store so far.”

Vibe will offer the area’s most extensive assortment of curated products featuring top-tier California brands and the Company’s Hype Cannabis Co. marijuana product lineup. This new dispensary will also offer retail home delivery of cannabis products directly to consumers throughout Monterey County and the Salinas Valley via Vibe By California’s online ordering and same-day delivery service.

Vibe Retail Expansion Strategy

Vibe’s management team continues to actively explore expansion opportunities as it looks to add new dispensaries to its portfolio to meet the growing demand for its Vibe By California and Hype Cannabis Co. products.

The new Vibe Salinas dispensary will join the Company’s existing California locations in Sacramento, Stockton, Redding, Palm Springs, Ukiah, plus Portland, Oregon. Vibe is positioned to execute its growth strategy of expanding its retail dispensary portfolio and scaling its cultivation business and Hype product offerings in California.

About Vibe Growth Corporation

Vibe Growth Corporation and its cannabis retail brand, Vibe By California, is a trusted, vertically integrated California cannabis enterprise with retail dispensaries; cannabis greenhouse cultivation; premium indoor cultivation; commercial cannabis distribution; brand sales and marketing; e-commerce platform; home delivery; and Hype Cannabis Co. marijuana and Vibe CBD products. In California, Vibe is focused on maximizing shareholder value through accelerating organic growth, opportunistic acquisitions, distressed workouts, and new license applications. The Company operates retail and e-commerce under its iconic Vibe By California brand.

To learn more about Vibe, please visit: www.vibebycalifornia.com.

Company Contact

Bill Mitoulas
Phone: +1 416.479.9547
Email: [email protected]
Website: www.vibebycalifornia.com

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Product & Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “anticipate”, “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events, and may be impacted as a result of general economic conditions or the ongoing COVID-19 endemic. In this news release, forward-looking statements relate to, among other things, the Company’s expectations of revenue, EBITDA profitability and adjusted funds flow, higher sales volumes, and the Company’s retail operations. Actual future results may differ materially.

The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. Risk factors related to the Company are described in the Company’s Management Discussion and Analysis, a copy of which is available under the Company’s profile on SEDAR.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any State securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities laws.

Unlike in Canada which has Federal legislation uniformly governing the cultivation, distribution, sale, and possession of medical cannabis under the Cannabis Act (Federal), readers are cautioned that in the U.S., cannabis is largely regulated at the State level. To the knowledge of Vibe Growth Corporation, there are to date a total of 33 states, plus the District of Columbia, that have legalized cannabis in some form. Notwithstanding the permissive regulatory environment of medical cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S. and as such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws concerning cannabis will neither absolve Vibe of liability under the U.S. Federal law nor will it provide a defense to any Federal proceeding, which may be brought against Vibe Growth Corporation. Any such proceedings brought against Vibe may adversely affect its operations and financial performance.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.